Ritter Pharma Cash Flow - Annual (NASDAQ:RTTR)

Add to My Stocks
$1.69 $0.02 (1.17%) RTTR stock closing price Sep 18, 2018 (Closing)

The financial analysis of RTTR requires an investor to check the cash flows for Ritter Pharma. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Ritter Pharma profits and Ritter Pharma debt. The cash flow statement is essetial while conducting the Ritter Pharma cash flow analysis and can be used to measure the operating performance of Ritter Pharma compared to various industry peers like PRVCF stock and PKPH stock. RTTR decrease in investments stood at a value of $-0.01M for the latest year 2017.

View details of Ritter Pharma cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2017201620152014
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----
Net Increase (Decrease) in Assets Liabilities-0.43M1.81M-0.24M-
Cash From (used in) Discontinued Operations----
Other Adjustments Net-1.35M3.31M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.01M-0.01M-
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments----
Other Cash Inflow (Outflow) from Investment Activities----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares25.02M7.04M21M-
Issuance (Repayment) of Debt Securities----
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities-2.03M-0.59M-2.19M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year7.04M15.81M2.74M-
Cash & Equivalents at Year End22.63M7.04M15.81M-
All figures in USD. M: Millions of USD, B: Billions of USD.

While Ritter Pharma stock price history provides the price history of a stock, Ritter Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Ritter Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Ritter Pharma stock price movement.
  • Cash Flow from operating activities: Ritter Pharma reported a negative operating cash flow of $-7.39M for 2017 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a negative value of $-0.01M for RTTR stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $22.99M for Ritter Pharma.

Key Financial Ratios For Ritter Pharma Cash Flow

Annual Cash Flow Statements For Ritter Pharmaceuticals Inc Peers

Ardelyx cash flow, Ventrus Biosciences cash flow, Brainstorm Cell cash flow, Peak Pharma cash flow